Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2010
07/08/2010US20100173924 Novel heterocycle compounds and uses thereof
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173910 Triaminopyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
07/08/2010US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/08/2010US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173163 Method for producing curing agent having acidic substituent and unsaturated maleimide group, thermosetting resin composition, prepreg, and laminate
07/08/2010US20100172623 Compound containing crosslinkable moieties, prepolymer, blend and polymer sheet obtained therefrom, and waveguide for optical interconnection
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
07/08/2010CA2747158A1 Phthalazinone and related analogs as sirtuin modulators
07/08/2010CA2746423A1 Aminopyrazole compounds as chki inhibitors
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2746220A1 Compositions of protein receptor tyrosine kinase inhibitors
07/08/2010CA2743700A1 Stereoselective synthesis of piperidine derivatives
07/07/2010EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
07/07/2010EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors
07/07/2010EP2203444A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
07/07/2010EP2203443A1 Prodrugs to thyroid hormone analogs
07/07/2010EP2203442A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
07/07/2010EP2203437A1 Chiral cis-imidazolines
07/07/2010EP2203436A1 Pyrazine derivatives and their use as potassium channel modulators
07/07/2010EP2203431A1 Anti-infective pyrimidines and uses thereof
07/07/2010EP2203430A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP2203427A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
07/07/2010EP1861380B1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
07/07/2010EP1670785B1 Salts and polymorphs of a pyrrole-substituted indolinone compound
07/07/2010EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors
07/07/2010EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101772494A 4-pyrimidinesulfamide derivative
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101772487A Novel compounds
07/06/2010US7750163 Cyanine dye labelling reagents
07/06/2010US7750154 Amide derivatives
07/06/2010US7750026 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases
07/06/2010US7750025 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
07/06/2010US7750011 Diazabicyclic aryl derivatives and their medical use
07/06/2010US7750010 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches
07/06/2010US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/06/2010US7749999 Alpha-ketoamides and derivatives thereof
07/06/2010US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
07/06/2010CA2177858C Benzimidazole derivatives, their preparation and their therapeutic use
07/01/2010WO2010074607A2 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
07/01/2010WO2010074409A2 3-aminopyrrolidine derivatives as ccr2 antagonists
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010074325A1 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
07/01/2010WO2010074193A1 Novel bicyclic heterocyclic compound
07/01/2010WO2010074088A1 Cyclic amine compounds
07/01/2010WO2010073128A2 Fused imidazole derivatives as trpv3 antagonist
07/01/2010WO2010073034A1 Pyrimidine indole derivatives for treating cancer
07/01/2010WO2010072296A1 Pyridazinone derivatives
07/01/2010WO2010072295A1 Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
07/01/2010WO2010036921A3 Slow release of organoboronic acids in cross-coupling reactions
07/01/2010WO2010033977A3 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
07/01/2010WO2010033678A3 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt
07/01/2010WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa
07/01/2010WO2010030785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease
07/01/2010WO2010025138A3 Pyrimidine compounds
07/01/2010WO2010024572A3 Material for organic photoelectric device and organic photoelectric device including the same
07/01/2010WO2010011924A3 Monomers derived from alpha-or beta-amino-e-caprolactam and polymers made therefrom
07/01/2010WO2010005876A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010WO2010005148A3 Novel isoindolinone derivatives having inhibitory activity against t-type calcium channel and method for preparation thereof
07/01/2010WO2009039431A3 Substituted aryl-fused spirocyclic amines
07/01/2010US20100168442 Pentaaryldiamine-containing bismaleimide compound and producing method thereof
07/01/2010US20100168420 Taxol Derivatives With Antitumor Activity
07/01/2010US20100168416 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010US20100168359 Tri-functional uv-absorbing compounds and use thereof
07/01/2010US20100168199 Kinase Inhibitors
07/01/2010US20100168189 Therapeutic substituted lactams
07/01/2010US20100168182 Compounds and compositions as kinase inhibitors
07/01/2010US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta
07/01/2010US20100168131 Novel compounds
07/01/2010US20100168123 Akt protein kinase inhibitors
07/01/2010US20100168120 Salts of pyridazine compounds
07/01/2010US20100168113 Pharmaceutical Compounds
07/01/2010US20100168110 Novel Compounds
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168106 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation
07/01/2010US20100168104 Hiv inhibiting 5-amido substituted pyrimidines
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168097 Non-Nucleoside Reverse Transcriptase Inhibitors
07/01/2010US20100168095 Multi-cyclic cinnamide derivatives
07/01/2010US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
07/01/2010US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists
07/01/2010US20100168082 Heterobicyclic Carboxamides as inhibitors for kinases
07/01/2010US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors
07/01/2010US20100167936 Use of ascorbic acid derivatives for the functionalization of matrices
07/01/2010US20100166837 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
07/01/2010US20100166819 Transforming Growth Factor Modulators
07/01/2010US20100166765 Benzoquinazoline derivatives
07/01/2010US20100166655 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
07/01/2010US20100163857 Material for organic photoelectric device, and organic photoelectric device including the same
07/01/2010US20100162495 Pentamethine cyanine azo complex dye compounds for optical data recording
07/01/2010DE102008062826A1 Pyridazinonderivate Pyridazinone derivatives
07/01/2010DE102006024834B4 Neue Indol-Pyrrol-Derivate und deren Verwendungen New indole-pyrrole derivatives and their uses
07/01/2010CA2772760A1 Small molecule inhibitors of necroptosis